This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Matthieu Giraud, Ph.D.
Global Director Peptide, Lipids and Carbohydrates Platforms at CordenPharma International

Profile

Dr. Matthieu Giraud joined CordenPharma in 2017 as Director, Global Peptides, Lipids & Carbohydrates Platforms, CordenPharma International. Prior to joining CordenPharma Matthieu held various senior positions in the CMO business, with >20 years of experience in increasingly senior roles, culminating as the Director, Head of R&D Peptides and Oligonucleotides at Lonza (CH), then Head of API production at BASF Pharma (CH), API Site Manager at BASF Pharma (FR), and finally Key Account Manager for Siegfried (CH). Matthieu has a Ph.D. in peptide chemistry from the University of Montpellier (FR), where he conducted research in the group of Prof. J. Martinez, jointly with Osaka University in the group of Prof. Shimonishi.

Agenda Sessions

  • Supporting mRNA-LNP Drug Products from Early R&D Programs to the Market – Scale Up and Production of mRNA Key Lipids

    15:00